Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

European Ombudsman demands EFSA admits failure over revolving door

  • Dansk
  • Nederlands
  • English
  • Suomi
  • Français
  • Deutsch
  • Ελληνικά
  • Italiano
  • Bokmål
  • Polski
  • Portuguese
  • Română
  • Slovenščina
  • Español
  • Svenska

Munich/ Brussels, 8 December 2011: The European Ombudsman has ruled in favour of a complaint filed by Testbiotech against the European Food Safety Authority (EFSA) regarding its approach to the 'revolving door'. The case concerns a former senior staff member at EFSA, Dr Suzy Renckens, who was head of the unit responsible for the risk assessment of genetically engineered plants for five years until 2008. Dr Renckens, a Belgian national, then moved to a job at Syngenta, a company that produces and markets these plants. The European Ombudsman has now agreed with Testbiotech's complaint and ruled that “EFSA should acknowledge that it failed to observe the relevant procedural rules and to carry out a sufficiently thorough assessment of the potential conflict of interests arising from the move of a former member of its staff to a biotechnology company”[1]. 

“The ruling from the Ombudsman shows in detail that EFSA failed to fulfill its obligations,” said Christoph Then from Testbiotech. “We are very concerned that both EFSA and the Commission have tried to deny their responsibilities in this case by rejecting our original complaints. The authority and the European Commission, which backs EFSA, are eroding confidence in European institutions. In consequence they are putting at risk the protection of consumers and the environment.”

Olivier Hoedeman from Corporate Europe Observatory said: “There have been other cases of staff going through the revolving door; EFSA should look carefully at the ruling and introduce a far stricter approach to conflicts of interest in the future. The Ombudsman makes some important recommendations which should lead to changes in how revolving door rules are implemented across the EU institutions, including at the Commission. We continue to see further scandalous revolving doors cases [2] and it is vital that the EU institutions, starting with the Commission, put improved rules and procedures in place to prevent future conflicts of interest, including a cooling off period of several years. It is time for a new start. No more business as usual.”

The Suzy Renckens case was made public by Testbiotech in November 2009 and the complaint was supported by Corporate Europe Observatory (CEO), Friends of the Earth Europe (FoEE) and Lobbycontrol (in Germany)[3]. EFSA now has until 31 March 2012 to respond to the judgement of the EU Ombudsman who has the power to table the issue in the European Parliament.

ENDS

Contact:

Testbiotech: Christoph Then, Tel +49 15154638040, info@testbiotech.org

CEO: Vicky Cann, Corporate Europe Observatory, tel: +32 28 93 09 30, mobile: +32 489 596 478

Notes:

[1] A link to the full ruling from the European Ombudsman can be found here: http://www.testbiotech.de/en/node/588

[2] CEO's RevolvingDoorWatch was launched on 7 December and it presents details of many other revolving door cases, including other cases at EFSA, and others concerning food industry lobbyists: http://www.corporateeurope.org/projects/revolvingdoorwatch

[3] All documents related to this complaint can be found here: http://www.testbiotech.de/independence

Related issues: 
 

Corporate Europe Observatory (CEO) today criticised the plenary vote of MEPs to approve the Jean-Claude Juncker Commission.
As MEPs prepare to quiz Jonathan Hill again, the UK commissioner-designate allocated the portfolio of financial services, and Hill refuses to answer MEPs' question about his former financial lobby clients, Corporate Europe Observatory (CEO) exposes further information about Hill's career as a lobbyist.
Attac Austria and Corporate Europe Observatory are today launching new 'wanted posters' about prospective members of the new European Commission, to expose details of their corporate backgrounds or other aspects of their careers which make them unsuitable to act as commissioner and promote the interests of 500 million European citizens.
A ruling by the European Ombudsman today that the European Commission should make its processes on revolving doors cases “more robust” to avoid conflicts of interest, has been welcomed by NGOs Corporate Europe Observatory, Friends of the Earth Europe, Greenpeace, LobbyControl and SpinWatch.
Our correspondence with Pr. Anne Glover, the current Chief Scientific Adviser to the President of the European Commission (CSA), on her role in the European Commission's review of endocrine disrupting chemicals shows how the very existence of her position was used by business-friendly interests to convey key messages to the top of the European Commission's hierarchy, playing a determining role in the massive delay now inflicted to the European Commission's handling of this important public health regulation. We ask that the CSA position is not renewed in the new Juncker Commission.
Will EFSA become more transparent, and to lobbyists or scientists? After its public consultation on its draft transparency policy, the Authority must now choose.
Corporate Europe Observatory (CEO) today criticised the plenary vote of MEPs to approve the Jean-Claude Juncker Commission.
CEO just responded to the European Ombudsman’s public consultation on transparency in the negotiations over the Transatlantic Trade and Investment Partnership (TTIP), outlining suggestions for ending the secrecy in the EU-US trade talks.

Corporate Europe Forum